Yılmaz Keskindemirci

ORCID: 0000-0003-3637-0620
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy
  • COVID-19 Pandemic Impacts
  • Vitamin C and Antioxidants Research
  • Intensive Care Unit Cognitive Disorders
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Vitamin D Research Studies
  • COVID-19 and healthcare impacts

Istanbul University-Cerrahpaşa
2021-2023

Istanbul University
2021

Background: We aimed to establish an acute treatment protocol increase serum vitamin D, evaluate the effectiveness of D3 supplementation, and reveal potential mechanisms in COVID-19. Methods: retrospectively analyzed data 867 COVID-19 cases. Then, a prospective study was conducted, including 23 healthy individuals 210 A total 163 cases had D 95 were followed for 14 days. Clinical outcomes, routine blood biomarkers, levels metabolism, action mechanism-related parameters evaluated. Results:...

10.3390/nu13114047 article EN Nutrients 2021-11-12

Abstract Background During the COVID-19 pandemic, health care systems are under extreme pressure. This study analyzed resource use (HCRU) and costs in patients admitted to hospital for aimed estimate one-year direct medical cost of disease Turkey. Methods retrospective cohort was conducted between March July 2020 a tertiary ( n = 1056) Istanbul. Patient demographics, clinical treatment characteristics at admission, comorbidities, severity, from payer perspective were evaluated using...

10.1186/s13561-021-00338-8 article EN cc-by Health Economics Review 2021-10-08

Healthcare workers are among risk groups in the COVID-19. Even if they not infected with disease, witness effects of pandemic. The aim study is to determine factors affecting COVID-19 vaccination status and reasons for vaccine hesitancy healthcare personnel our hospital. Firstly, demographic characteristics all was evaluated. After that, a survey applied 408 vaccinated 297 nonvaccinated personnel. Within first month after beginning vaccination, 66% 3937 received vaccine. number higher...

10.3390/vaccines9111343 article EN cc-by Vaccines 2021-11-17

This study aims to evaluate the cost-effectiveness of remdesivir compared other existing therapies (SoC) in Turkey treat COVID-19 patients hospitalized with < 94% saturation and low-flow oxygen therapy (LFOT) requirement. We as treatment for treatments Turkish guidelines. Analyses were performed using data from 78 SpO2 who received LFOT a tertiary healthcare facility. episode costs calculated considering cost modeled same group payer's perspective. The incremental ratio (ICER) per...

10.1007/s12325-021-01874-9 article EN cc-by-nc Advances in Therapy 2021-08-11

The evidence on the waning protection of COVID-19 vaccines has been reviewed by World Health Organization and led to consideration need for booster doses. This study aimed evaluate vaccine effectiveness against COVID-19, infections among healthcare workers who received various types (inactive or m-RNA) doses (2 4 doses) vaccine. was conducted with a total 3,009 between August 1 November 30, 2021 at university hospital. Six different vaccination statuses were evaluated in study. infection,...

10.1080/21645515.2023.2275445 article EN cc-by-nc Human Vaccines & Immunotherapeutics 2023-11-15

Limited data exists to date on the predictors for development of pneumonia in patients with mild and moderate coronavirus (COVID-19). In this study, it was aimed evaluate demographic characteristics clinical findings COVID-19 determine risk factors admitted pandemic outpatient clinic a university hospital. A total 414 laboratory confirmed were included. Of these, 220 (53.1%) male, mean age 38.3 ± 12.7. Median duration hospital admission from onset symptoms three days (0-11). cases, 154...

10.5578/mb.20219805 article EN Mikrobiyoloji Bulteni 2021-07-16
Coming Soon ...